Author byline as per print journal: Pieter J Glerum1,2, MSc; Mert Hayta1,3, PharmD, MSc; David M Burger5, PharmD, PhD; Cees Neef6, PharmD, PhD; Marcel L Bouvy3, PharmD, PhD; Marc Maliepaard1,4, PhD
Background: Patients may experience clinical discomfort as a result of drug switches between drug products with the same active substance. Although a large market share of generic drugs is financially favourable, reduction of the number of drug switches should be strived for. However, specific causes for the drug switches are currently undocumented.
Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.